Latest stories on ANIP
ANI Pharmaceuticals initiated with an Outperform at Leerink
The Fly61 · neutralanalyst
ANI Pharmaceuticals to Present at September Investor Conferences
GlobeNewswire56 · neutralgeneral
ANI Pharmaceuticals to Present at September Investor Conferences
Business Insider56 · neutralgeneral
ANI Pharmaceuticals reshapes board to advance rare disease strategy
TipRanks56 · neutralgeneral
ANI PHARMACEUTICALS INC (ANIP) files 8-K
SEC 8-K50 · neutralgeneral
ANI Pharmaceuticals Earnings Call Signals Growth Momentum
TipRanks63 · neutralearnings
ANI Pharmaceuticals (ANIP) Q2 2026 Earnings Call Transcript
The Motley Fool67 · bullishearnings
ANI Pharmaceuticals price target lowered to $119 from $124 at Guggenheim
The Fly42 · neutralanalyst
ANI Pharmaceuticals price target lowered to $90 from $91 at Canaccord
The Fly48 · neutralanalyst
ANI Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
ANI Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings
ANI projects $1.08B-$1.14B 2026 revenue as it revises Cortrophin to $520M-$540M amid gout sales force expansion
Seeking Alpha63 · neutralearnings
ANI Pharmaceuticals, Inc. (ANIP) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
ANI Pharmaceuticals Shares Slide Despite Earnings Beat After Cortrophin Outlook Cut
InvestorsHub38 · neutralearnings
ANI Pharmaceuticals Posts Record Q2 2026 Results
TipRanks73 · bullishearnings
ANI PHARMACEUTICALS INC (ANIP) files 8-K
SEC 8-K50 · neutralgeneral
Ani Pharmaceuticals Backs Fy26 Adjusted Eps View 9 19 9 69 Consensus 9 42
The Fly58 · neutralearnings
ANI Pharmaceuticals backs FY26 revenue view $1.08B-$1.14B, consensus $1.12B
The Fly56 · neutralearnings
Ani Pharmaceuticals Reports Q2 Adjusted Eps 2 21 Consensus 2 04
The Fly67 · bullishearnings
ANI Pharmaceuticals Non-GAAP EPS of $2.21 beats by $0.17, revenue of $266.04M beats by $5.91M
Seeking Alpha68 · bullishearnings
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results
Business Insider73 · bullishearnings
ANI Pharmaceuticals Q2 2026 Earnings Preview
Seeking Alpha55 · neutralearnings
ANI Pharmaceuticals: The Market Is Pricing The Present, Not The Future
Seeking Alpha58 · neutralanalyst
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
Business Insider50 · neutralearnings
Is ANIP Stock Undervalued at 10x Forward Earnings and $93 Target?
Quartz58 · neutralanalyst